The value of performance status in predicting venous thromboembolism in lung cancer patients treated with immune checkpoint inhibitors

CONCLUSION: VTE occurred in 9.4% of lung cancer patients treated with ICIs, and poor performance status was associated with an increased risk of VTE.PMID:38377652 | DOI:10.1016/j.ejon.2024.102527
Source: European Journal of Oncology Nursing - Category: Nursing Authors: Source Type: research